Date: Sun 01/09/2019 - Sat 31/10/2020
Provider: Luxottica Institute of Learning
Optometrist Credits: 0.50 General Credits
Event Type(s): Online
Contact
Email: iol@luxottica.com.au
Number: 09 929 3274
This article provides an overview of unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) including how the burden of treatment may lead to patients stopping therapy. Approaches to minimising the treatment burden and improving patient outcomes are also discussed.
LEARNING OBJECTIVES
- Gain an improved understanding of the unmet needs of Australian patients with nAMD
- Be able to consider the impact of factors that contribute to nAMD treatment discontinuation, including:Treatment-related anxiety; Economic considerations; Travel considerations; Caregiver burden; Older age and comorbidities; Poor clinical response and unmet expectation.
- Be able to identify and evaluate ways to reduce the treatment burden in nAMD in Australia